Boston Scientific Adds Single-Shot AF-Ablation Balloon With Apama Acquisition
Executive Summary
Boston Scientific will pay about $300m for the Campbell, California-based maker of the Apama radiofrequency balloon catheter system for the treatment of atrial fibrillation. Boston Scientific plans to integrate Apama's technology with its Rhythmia HDx mapping system.
You may also be interested in...
Boston Scientific Gulps Down Claret After Cryterion, In Double-Whammy July
Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second acquisition in the space of two weeks.
Global Approvals Analysis: Emerging Markets Drive Volume Of OUS Approvals
The numbers of medical device approvals were up in most regions outside the US and the biggest surge, by percentage, was in approvals from emerging markets and the so-called BRIC countries. It remains to be seen if the trend will continue in 2018, but many companies are already counting on important non-US approvals coming in the next year.
Start-Up Spotlight: Apama Medical, Targeting AFib With An RF-Balloon Combo
Founded and led by serial entrepreneur Amr Salahieh, Apama Medical is developing a system that aims to combine the advantages of two approaches for treating atrial fibrillation: point-by-point radiofrequency-based ablation and cryoballoon ablation.